Local amphotericin B therapy for Cutaneous Leishmaniasis: A systematic review
PLOS Neglected Tropical Diseases · 16.04.2024 · 18 (4) · e0012127
DOI: 10.1371/journal.pntd.0012127 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift PLOS Neglected Tropical Diseases, online erschienen am 16.04.2024. Verfasst von Líndicy Leidicy Alves und 4 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Research and Public Policy Group on Infectious and Parasitic Diseases-René Rachou Institute-Fundação Oswaldo Cruz-FIOCRUZ, Belo Horizonte, M…. Hauptthemen laut MEDLINE: Leishmaniasis, Cutaneous, Amphotericin B, Antiprotozoal Agents. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq).
Abstract (Originalsprache)
Background
Cutaneous leishmaniasis (CL) is characterized by potentially disfiguring skin ulcers carrying significant social stigma. To mitigate systemic drug exposure and reduce the toxicity from available treatments, studies addressing new local therapeutic strategies using available medications are coming up. This review systematically compiles preclinical and clinical data on the efficacy of amphotericin B (AmB) administered locally for cutaneous leishmaniasis. Methodology Structured searches were conducted in major databases. Clinical studies reporting cure rates and preclinical studies presenting any efficacy outcome were included. Exclusion criteria comprised nonoriginal studies, in vitro investigations, studies with fewer than 10 treated patients, and those evaluating AmB in combination with other antileishmanial drug components. Principal findings A total of 21 studies were identified, encompassing 16 preclinical and five clinical studies. Preclinical assessments generally involved the topical use of commercial AmB formulations, often in conjunction with carriers or controlled release systems. However, the variation in the treatment schedules hindered direct comparisons. In clinical studies, topical AmB achieved a pooled cure rate of 45.6% [CI: 27.5–64.8%; I2 = 79.7; p = 0.002), while intralesional (IL) administration resulted in a 69.8% cure rate [CI: 52.3–82.9%; I2 = 63.9; p = 0.06). In the direct comparison available, no significant difference was noted between AmB-IL and meglumine antimoniate-IL administration (OR:1.7; CI:0.34–9.15, I2 = 79.1; p = 0.00), however a very low certainty of evidence was verified.
Conclusions
Different AmB formulations and administration routes have been explored in preclinical and clinical studies. Developing therapeutic technologies is evident. Current findings might be interpreted as a favorable proof of concept for the local AmB administration which makes this intervention eligible to be explored in future well-designed studies towards less toxic treatments for leishmaniasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Clinical Research and Public Policy Group on Infectious and Parasitic Diseases-René Rachou Institute-Fundação Oswaldo Cruz-FIOCRUZ, Belo Horizonte, Minas Gerais, Brazil.
ORCID-Profile: Líndicy Leidicy Alves
Förderung
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
Zitieren
APA
Alves, L. L., Freire, M. L., Troian, I. L., Morais-Teixeira, E., & Cota, G. (2024). Local amphotericin B therapy for Cutaneous Leishmaniasis: A systematic review. PLOS Neglected Tropical Diseases, 18(4), e0012127. https://doi.org/10.1371/journal.pntd.0012127
Vancouver
Alves LL, Freire ML, Troian IL, Morais-Teixeira E, Cota G. Local amphotericin B therapy for Cutaneous Leishmaniasis: A systematic review. PLOS Neglected Tropical Diseases. 2024;18(4):e0012127. doi:10.1371/journal.pntd.0012127
BibTeX
@article{Alves2024,
author = {Alves, Líndicy Leidicy and Freire, Mariana Lourenço and Troian, Isadora Lana and Morais-Teixeira, Eliane de and Cota, Gláucia},
title = {Local amphotericin B therapy for Cutaneous Leishmaniasis: A systematic review},
journal = {PLOS Neglected Tropical Diseases},
year = {2024},
volume = {18},
number = {4},
pages = {e0012127},
doi = {10.1371/journal.pntd.0012127}
}
EUVIMED